# A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation

> **NCT02513810** · NA · UNKNOWN · sponsor: **Yonsei University** · enrollment: 3020 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** BioFreedom with 1 month DAPT
- **DEVICE:** BioMatrix or Ultimaster with 6 to 12 months DAPT

## Key facts

- **NCT ID:** NCT02513810
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12-02
- **Primary completion:** 2019-09-17
- **Final completion:** 2020-09
- **Target enrollment:** 3020 (ESTIMATED)
- **Last updated:** 2020-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02513810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02513810, "A Randomized Controlled Comparison Between One Versus More Than Six Months of Dual Antiplatelet Therapy After Biolimus A9-eluting Stent Implantation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02513810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*